Virtual event takes place December 1, 2022 ROCHESTER, Mich. , Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the third annual Innovate4Outcomes ®
ROCHESTER, Mich. , Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Tuesday, November 8, 2022, at 4:30 p.m.
Analysis demonstrates effectiveness of OptimizeRx’s real-world evidence solution to identify patients suitable for a specialty therapy within a narrow timeframe ROCHESTER, Mich. , Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care
Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich. , Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping
ROCHESTER, Mich. , Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the following September conferences on the
Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for doctors and patients navigating Medicare coverage gaps ROCHESTER, Mich. , Aug.
Revenue Up 3% to $14.0 million , driven by new customer and program launches Increase in breadth and scope of brand deal size represents further momentum in the validation of our value proposition Generated $4.4 million in cash flow from operations during the first half of 2022 ROCHESTER, Mich.
Revenue Up 3% to $14.0 million , driven by new customer and program launches Increase in breadth and scope of brand deal size represents further momentum in the validation of our value proposition Generated $4.4 million in cash flow from operations during the first half of 2022 ROCHESTER, Mich.
Healthcare advertising agencies can now easily add retail pharmacies to their healthcare media buying strategies ROCHESTER, Mich. , July 26, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and
ROCHESTER, Mich. , July 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Tuesday, August 9, 2022, at 4:30 p.m.
